Cargando…
Association of Selected State Policies and Requirements for Buprenorphine Treatment With Per Capita Months of Treatment
IMPORTANCE: Expanding the use of buprenorphine for treating opioid use disorder is a critical component of the US response to the opioid crisis, but few studies have examined how state policies are associated with buprenorphine dispensing. OBJECTIVE: To examine the association of 6 selected state po...
Autores principales: | Stein, Bradley D., Saloner, Brendan K., Golan, Olivia K., Andraka-Christou, Barbara, Andrews, Christina M., Dick, Andrew W., Davis, Corey S., Sheng, Flora, Gordon, Adam J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10220518/ https://www.ncbi.nlm.nih.gov/pubmed/37234015 http://dx.doi.org/10.1001/jamahealthforum.2023.1102 |
Ejemplares similares
-
Differences in medicaid expansion effects on buprenorphine treatment utilization by county rurality and income: A pharmacy data claims analysis from 2009–2018
por: Golan, Olivia K., et al.
Publicado: (2023) -
Buprenorphine Treatment Episodes During the First Year of COVID: a Retrospective Examination of Treatment Initiation and Retention
por: Stein, Bradley D., et al.
Publicado: (2022) -
Prior authorization restrictions on medications for opioid use disorder: trends in state laws from 2005 to 2019
por: Andraka-Christou, Barbara, et al.
Publicado: (2023) -
A national survey of state laws regarding medications for opioid use disorder in problem-solving courts
por: Andraka-Christou, Barbara, et al.
Publicado: (2022) -
Per Capita Payments for Clinical Trials
por: Connolly, C. K., et al.
Publicado: (1992)